IHL having zero sales revenue has been mentioned a few times now, they dont have a product to produce revenue, or finalised trials, yet the sp is up 100% in 3 months, it just highlights how innovative and exciting IHL are, their trials if successful could be lifechanging to millions.
IRX have made a 'medical inhalation device' - a vape.
Vapes are already being used worldwide with cannabis oil. Will their vape along with FDA approval be enough to reach IHL current market cap? who knows
Although it is good to ride the wave where possible Sud Argawal being involved isnt enough for the companies to be likened. I personally believe to reach IHL there would need to be a transition to biotech, and then also a reasonable comparison could be made.
With Argawal and Saich on board, both already involved in biotechs who knows where this company is headed. Interestingly enough Saich's linkedin shows he was CMO at Senzer working on 'pharmaceutical grade cannabinoid inhalers' but the funding fell through and he was made redundant, lucky for you lot he has been abe able to transfer his knowledge to Inhalerx.
Add to My Watchlist
What is My Watchlist?
